Cochrane · systematic review · CD007170
Cinnamon for diabetes mellitus
Leach, MJ, Kumar, S · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library
Metabolic and Endocrine DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
2
No studies
4
Included studies
NR
No studies 4 · 66.7%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 33.3%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: patients with diabetes mellitus
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Death from any cause ( | no estimate extracted | NR | No studies |
Morbidity ( | no estimate extracted | NR | No studies |
Health‐related quality of life ( | no estimate extracted | NR | No studies |
Adverse events ( | no estimate extracted | 4 studies · 264 participants | Moderate Downgraded: risk of bias |
Costs ( | no estimate extracted | NR | No studies |
HbA1c ( | no estimate extracted | 6 studies · 405 participants | Moderate Downgraded: risk of bias, imprecision |